Intriguingly, ablation of the mitophagy receptor FUNDC1 negated the beneficial effects of CK2α deletion on body weight, liver weight, WAT (epididymal and inguinal), and glucose intolerance under HFD challenge, while FUNDC1 deletion alone did not produce any significant effects (Figure 2A–I). This evidence concerns the gene FUNDC1 and Glucose intolerance.